UCDC: Predicting Disease Severity in Males with Ornithine Transcarbamylase Deficiency
Nov 7, 2022 ·
2m 2s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on October 10, 2022,...
show more
New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on October 10, 2022, titled "Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency."
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51668
Learn more about UCDC: https://www1.rarediseasesnetwork.org/cms/ucdc
show less
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51668
Learn more about UCDC: https://www1.rarediseasesnetwork.org/cms/ucdc
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments